169
Views
11
CrossRef citations to date
0
Altmetric
Research Article

In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin

, , , , , , & show all
Pages 623-629 | Received 08 Oct 2017, Accepted 18 Nov 2018, Published online: 09 Dec 2018

References

  • Chen S, Qu X, Wan P, Li QW, Wang Z, Guo F, Bai L, Hu Z, Tan W, Li J. 2013. Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells. Am J Chin Med. 41:665–682.
  • Chu K, Chen L, Xu W, Li H, Zhang Y, Xie W, Zheng J. 2013. Preparation of a paeonol-containing temperature-sensitive in situ gel and its preliminary efficacy on allergic rhinitis. Int J Mol Sci. 14:6499–6515.
  • Deng LP, Dong J, Cai H, Wang W. 2013. Cantharidin as an antitumor agent: a retrospective review. Curr Med Chem. 20:159–166.
  • Dessì M, Borzacchiello A, Mohamed TH, Abdel-Fattah WI, Ambrosio L. 2013. Novel biomimetic thermosensitive β-tricalcium phosphate/chitosan-based hydrogels for bone tissue engineering. J Biomed Mater Res A. 101:2984–2993.
  • Gandra SC, Nguyen S, Nazzal S, Alayoubi A, Jung R, Nesamony J. 2015. Thermoresponsive fluconazole gels for topical delivery: rheological and mechanical properties, in vitro drug release and anti-fungal efficacy. Pharm Dev Technol. 20:41–49.
  • Li Y, Sun Y, Liu F, Sun L, Li J, Duan S, Liu H, Peng Y, Xiao L, Liu Y, et al. 2013. Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition. PLoS One. 8:e66356.
  • Lin Z, Mei D, Chen M, Wang Y, Chen X, Wang Z, He B, Zhang H, Wang X, Dai W, et al. 2015. A comparative study of thermo-sensitive hydrogels with water-insoluble paclitaxel in molecule, nanocrystal and microcrystal dispersions. Nanoscale. 7:14838–14847.
  • Liu MC, Liu L, Wang XR, Shuai WP, Hu Y, Han M, Gao JQ. 2016. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo. Int J Nanomedicine. 11:1395–1412.
  • Lu C, Liu M, Fu H, Zhang W, Peng G, Zhang Y, Cao H, Luo L. 2015. Novel thermosensitive in situ gel based on poloxamer for uterus delivery. Eur J Pharm Sci. 77:24–28.
  • Ma J, Teng H, Wang J, Zhang Y, Ren T, Tang X, Cai C. 2014. A highly stable norcantharidin loaded lipid microspheres: preparation, biodistribution and targeting evaluation. Int J Pharm. 473:475–484.
  • Nanjwade BK, Deshmukh RV, Gaikwad KR, Parikh KA, Manvi FV. 2012. Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride. Eur J Drug Metab Pharmacokinet. 37:117–123.
  • Ren J, Li G, Zhao W, Lin L, Ye T. 2016. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: therapeutic effects andmolecular mechanisms. World J Gastroenterol. 22:3962–3968.
  • Salis A, Rassu G, Budai-Szűcs M, Benzoni I, Csányi E, Berkó S, Maestri M, Dionigi P, Porcu EP, Gavini E, et al. 2015. Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: a preliminary study. Expert Opin Drug Deliv. 12:1583–1596.
  • Singh NK, Lee DS. 2014. In situ gelling pH- and temperature-sensitive biodegradable block copolymer hydrogels for drug delivery. J Control Release. 193:214–227.
  • Wang D, Zhao J, Liu X, Sun F, Zhou Y, Teng L, Li Y. 2014. Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation. Eur J Pharm Sci. 60:40–48.
  • Wu G, Yuan Y, He J, Li Y, Dai X, Zhao B. 2016. Stable thermosensitive in situ gel-forming systems based on the lyophilizate of chitosan/α,β-glycerophosphate salts. Int J Pharm. 511:560–569.
  • Xie MH, Cai XJ, Peng JB, Jiang XR, Ge M. 2017. Study on preparation and anti-hepatoma of norcantharidin thermosensitive in-situ gel. Chin J Mod Appl Pharm. 34:1262–1265.
  • Xiong X, Wu M, Zhang H, Li J, Lu B, Guo Y, Zhou T, Guo H, Peng R, Li X, et al. 2015. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma. Int J Oncol. 47:1321–1328.
  • Yang H, Guo W, Xu B, Li M, Cui J. 2007. Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma. Anticancer Drugs. 18:1133–1137.
  • Yang PY, Hu DN, Kao YH, Lin IC, Chou CY, Wu YC. 2016. Norcantharidin induces apoptosis in human prostate cancer cells through both intrinsic and extrinsic pathways. Pharmacol Rep. 68:874–880.
  • Yu T, Hou F, Liu M, Zhou L, Li D, Liu J, Fan Z, Li Q. 2012. Norcantharidin anti-angiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer. Asian Pac J Cancer Prev. 13:499–503.
  • Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W. 2012. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Int J Oncol. 40:1501–1514.
  • Zhou F, Xie MH, Zhou HQ, Cai XJ, Ni JJ, Wang Z. 2017. Studies on preparation and drug release characteristics of norcantharidin temperature-sensitive in situ gel in vitro. Chin J Clin Pharm. 26:177–180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.